Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CRN’s board changes

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition has elected Marjorie Fine, executive VP and general council for Shaklee, as chair, CRN announces Dec. 7. Fine will succeed Kemin Health Senior VP Chuck Brice as chair of the association and will hold the office from January 2007 through December 2008. "During my two-year term, I intend to work closely with [CRN President] Steve [Mister] and cooperatively with our member companies, on an agenda that focuses on industry responsibility and further acceptance of our products as part of mainstream healthcare," Fine says in a statement. Brice will remain on CRN's board of directors and executive committee. Other newly elected officers to the board include Chair-elect Mark LeDoux, of Natural Alternative International; Treasurer David Christensen, of Bayer; and Secretary Joe LaPlaca, of DSM Nutritional Products...

You may also be interested in...

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 

Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California

US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts